Back to Search
Start Over
Profit-driven drug testing.
- Source :
-
Journal of pain & palliative care pharmacotherapy [J Pain Palliat Care Pharmacother] 2012; Vol. 26 (1), pp. 13-7. Date of Electronic Publication: 2012 Feb 13. - Publication Year :
- 2012
-
Abstract
- Random drug testing of people being treated for chronic pain has become more common. Physicians may drug test patients on opioid therapy as a result of concerns over prosecution, drug misuse, addiction, and overdose. However, profit motive has remained unexplored. This article suggests profits also drive physician drug-testing behavior and evidence is offered, including an exploration of Medicare reimbursement incentives and kickbacks for drug testing.
- Subjects :
- Analgesics, Opioid therapeutic use
Chronic Pain drug therapy
Humans
Laboratories economics
Laboratories legislation & jurisprudence
Medicare Part B statistics & numerical data
Opioid-Related Disorders drug therapy
Opioid-Related Disorders economics
Substance Abuse Detection legislation & jurisprudence
United States
Analgesics, Opioid adverse effects
Medicare Part B economics
Substance Abuse Detection economics
Subjects
Details
- Language :
- English
- ISSN :
- 1536-0539
- Volume :
- 26
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of pain & palliative care pharmacotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 22329745
- Full Text :
- https://doi.org/10.3109/15360288.2011.650358